|
|
|
Insider
Information: |
Halak Brian K |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
28 |
|
Direct
Shares |
10,552,431 |
|
Indirect Shares
|
959,812 |
|
|
Direct
Value |
$68,450,408 |
|
|
Indirect Value
|
$10,322,309 |
|
|
Total
Shares |
11,512,243 |
|
|
Total
Value |
$78,772,717 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Northstar Neuroscience Inc |
NSTR |
Director |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
3,415 |
2008-04-24 |
56,718 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
4,529 |
2011-12-22 |
50,643 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2006-05-09 |
100,355 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2010-03-26 |
7,276 |
2010-03-26 |
0 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
2014-11-17 |
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2015-03-20 |
2,216,935 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
55,296 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-21 |
17,171 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
2016-05-26 |
606,283 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2014-09-10 |
2,763,294 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
25,730 |
2018-11-06 |
19,150 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Otonomy, Inc. |
OTIC |
10% Owner |
2014-08-18 |
11,715 |
2014-08-18 |
0 |
Premium* |
|
Atara Biotherapeutics, Inc. |
ATRA |
10% Owner |
2014-10-21 |
15,890 |
2014-10-21 |
0 |
Premium* |
|
Evofem Biosciences Inc |
EVFM |
10% Owner |
2014-11-25 |
3,091,643 |
2014-11-25 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
10% Owner |
2015-05-12 |
13,414 |
2015-05-12 |
0 |
Premium* |
|
Glaukos Corp |
GKOS |
10% Owner |
2015-06-30 |
6,501 |
2015-06-30 |
0 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
Director |
2021-09-17 |
327 |
2015-07-16 |
0 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
10% Owner |
2016-03-08 |
5,641 |
2016-03-08 |
0 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2019-08-06 |
813,433 |
2016-10-12 |
0 |
Premium* |
|
Bionano Genomics, Inc |
BNGO |
10% Owner |
2018-08-23 |
943,878 |
2018-08-23 |
0 |
Premium* |
|
Alliqua BioMedical Inc |
ALQA |
10% Owner |
2019-05-03 |
22,527 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2012-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
93,434 |
93,434 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2006-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100,355 |
|
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
B |
$4.00 |
$9,399,996 |
I/I |
2,349,999 |
110,555 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-01-18 |
4 |
A |
$0.00 |
$0 |
I/I |
66,462 |
159,896 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
169,251 |
1.5 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-05-26 |
4 |
S |
$4.70 |
$1,617,364 |
D/D |
(344,120) |
606,283 |
0 |
- |
|
SNDX |
Syndax Pharmaceuticals In... |
10% Owner |
|
2016-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
761,062 |
761,062 |
0 |
- |
|
RSLS |
ReShape Lifesciences Inc |
10% Owner |
|
2019-08-06 |
4 |
B |
$4.00 |
$1,000,000 |
D/D |
250,000 |
813,433 |
2.45 |
- |
|
GKOS |
Glaukos Corp |
10% Owner |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
876,083 |
876,083 |
0 |
- |
|
BNGO |
Bionano Genomics, Inc |
10% Owner |
|
2018-08-23 |
4 |
A |
$0.00 |
$1,550,015 |
D/D |
928,878 |
929,878 |
0 |
- |
|
BNGO |
Bionano Genomics, Inc |
10% Owner |
|
2018-08-23 |
4 |
B |
$6.13 |
$91,875 |
D/D |
15,000 |
943,878 |
2.45 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-27 |
4 |
S |
$5.02 |
$18,087 |
D/D |
(3,603) |
950,403 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-25 |
4 |
S |
$5.20 |
$7,758 |
D/D |
(1,492) |
954,006 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-20 |
4 |
S |
$5.29 |
$23,403 |
D/D |
(4,424) |
955,498 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-19 |
4 |
S |
$5.36 |
$198,609 |
D/D |
(37,054) |
959,922 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-11 |
4 |
S |
$5.22 |
$22,697 |
D/D |
(4,348) |
996,976 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-08 |
4 |
S |
$5.35 |
$77,864 |
D/D |
(14,554) |
1,001,324 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-07 |
4 |
S |
$5.26 |
$146,128 |
D/D |
(27,781) |
1,015,878 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2016-04-06 |
4 |
S |
$5.22 |
$45,252 |
D/D |
(8,669) |
1,043,659 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2015-08-18 |
4 |
S |
$7.02 |
$83,089 |
D/D |
(11,836) |
1,052,328 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2015-04-16 |
4 |
S |
$7.07 |
$229,146 |
D/D |
(32,411) |
1,064,164 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2015-04-15 |
4 |
S |
$7.58 |
$60,034 |
D/D |
(7,920) |
1,096,575 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2015-04-14 |
4 |
S |
$7.78 |
$76,493 |
D/D |
(9,832) |
1,104,495 |
0 |
- |
|
OTIC |
Otonomy, Inc. |
10% Owner |
|
2014-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,548,792 |
1,548,792 |
0 |
- |
|
OTIC |
Otonomy, Inc. |
10% Owner |
|
2014-08-18 |
4 |
D |
$16.00 |
$595,584 |
D/D |
(37,224) |
1,579,323 |
0 |
- |
|
152 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|